Inhibikase Therapeutics, Inc.
IKT
$2.37
$0.010.42%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -80.73% | -62.07% | -62.09% | -42.51% | -36.57% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.15% | -36.11% | -7.99% | 336.82% | -27.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 85.32% | -26.41% | -75.49% | -78.10% | -61.08% |
| Total Current Assets | -76.13% | -60.87% | -60.88% | -41.69% | -37.29% |
|
|
|||||
| Total Current Assets | -76.13% | -60.87% | -60.88% | -41.69% | -37.29% |
| Net Property, Plant & Equipment | -43.39% | -38.39% | -51.33% | -47.70% | -44.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -75.52% | -60.50% | -60.70% | -41.83% | -37.44% |
|
|
|||||
| Total Accounts Payable | 244.30% | 77.76% | 34.90% | -43.82% | -5.97% |
| Total Accrued Expenses | 16.32% | 11.12% | 60.93% | -5.77% | -18.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.55% | 2.84% | 2.93% | 2.95% | 4.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 78.99% | 35.55% | 58.89% | -6.95% | -14.67% |
|
|
|||||
| Total Current Liabilities | 78.99% | 35.55% | 58.89% | -6.95% | -14.67% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -82.93% | -67.27% | -56.16% | -47.84% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 71.42% | 29.38% | 50.98% | -9.54% | -16.90% |
|
|
|||||
| Common Stock & APIC | 5.16% | 5.17% | 1.06% | 13.19% | 13.16% |
| Retained Earnings | -31.19% | -31.62% | -36.68% | -39.75% | -43.88% |
| Treasury Stock & Other | 1,900.00% | 41.18% | -101.09% | -99.14% | -100.37% |
| Total Common Equity | -103.53% | -73.82% | -73.24% | -47.81% | -40.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -103.53% | -73.82% | -73.24% | -47.81% | -40.25% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -103.53% | -73.82% | -73.24% | -47.81% | -40.25% |
|
|
|||||
